JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Intuitive Surgical Inc

Cerrado

SectorSalud

471.65 0.36

Resumen

Variación precio

24h

Actual

Mínimo

469.77

Máximo

475.46

Métricas clave

By Trading Economics

Ingresos

-45M

658M

Ventas

187M

2.4B

P/B

Media del Sector

67.603

34.393

BPA

1.81

Margen de beneficio

26.984

Empleados

15,638

EBITDA

268M

987M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+28.25% upside

Dividendos

By Dow Jones

Próximas Ganancias

16 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-12B

173B

Apertura anterior

471.29

Cierre anterior

471.65

Noticias sobre sentimiento de mercado

By Acuity

10%

90%

5 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Intuitive Surgical Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

22 jul 2025, 21:13 UTC

Ganancias

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 abr 2025, 20:55 UTC

Ganancias

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 ene 2025, 21:41 UTC

Ganancias

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 ene 2025, 18:37 UTC

Adquisiciones, fusiones, absorciones

Intuitive to Establish Direct Presence in Europe With Acquisition

22 jul 2025, 20:14 UTC

Ganancias

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 jul 2025, 20:13 UTC

Ganancias

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 jul 2025, 20:13 UTC

Ganancias

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Net $658.4M >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 abr 2025, 20:13 UTC

Ganancias

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Net $698.4M >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 ene 2025, 21:17 UTC

Ganancias

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 ene 2025, 18:18 UTC

Ganancias

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 ene 2025, 13:11 UTC

Principales Noticias

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 ene 2025, 09:51 UTC

Acciones populares

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 ene 2025, 21:10 UTC

Ganancias

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 ene 2025, 21:09 UTC

Ganancias

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 ene 2025, 21:09 UTC

Ganancias

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Net $685.7M >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q EPS $1.88 >ISRG

Comparación entre iguales

Cambio de precio

Intuitive Surgical Inc Esperado

Precio Objetivo

By TipRanks

28.25% repunte

Estimación a 12 meses

Media 602.89 USD  28.25%

Máximo 685 USD

Mínimo 440 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intuitive Surgical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

22 ratings

17

Comprar

4

Mantener

1

Vender

Puntuación técnica

By Trading Central

514.59 / 539.05Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

5 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.